Remdesivir use may be managed by government

The recommendations come as four Indian drug companies, Cipla, Hetero, Mylan and Jubilant, gear up to get an approval for the drug in the treatment of Covid-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eCZqmx
via IFTTT